4//SEC Filing
Szot Matthew K 4
Accession 0001213900-25-082821
CIK 0001937993other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 8:35 PM ET
Size
7.1 KB
Accession
0001213900-25-082821
Insider Transaction Report
Form 4
Szot Matthew K
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-08-27$13.99/sh−1,600$22,392→ 31,733 total - Sale
Common Stock
2025-08-28$14.00/sh−400$5,600→ 31,333 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.00. The reporting person undertakes to provide to Cadrenal Therapeutics, Inc., any security holder of Cadrenal Therapeutics, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions, each at $14.000. The reporting person undertakes to provide to Cadrenal Therapeutics, Inc., any security holder of Cadrenal Therapeutics, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Cadrenal Therapeutics, Inc.
CIK 0001937993
Entity typeother
Related Parties
1- filerCIK 0001401385
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 8:35 PM ET
- Size
- 7.1 KB